Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 20, 2026.

The genetics of circadian rhythms, sleep and health

Aarti Jagannath, Lewis Taylor, Zeinab Wakaf and 2 more

Human Molecular Genetics · 2017 · Review · CC BY

doi:10.1093/hmg/ddx240

Abstract

Circadian rhythms are 24-h rhythms in physiology and behaviour generated by molecular clocks, which serve to coordinate internal time with the external world. The circadian system is a master regulator of nearly all physiology and its disruption has major consequences on health. Sleep and circadian rhythm disruption (SCRD) is a ubiquitous feature in today's 24/7 society, and studies on shift-workers have shown that SCRD can lead not only to cognitive impairment, but also metabolic syndrome and psychiatric illness including depression (1,2). Mouse models of clock mutants recapitulate these deficits, implicating mechanistic and causal links between SCRD and disease pathophysiology (3-5). Importantly, treating clock disruption reverses and attenuates these adverse health states in animal models (6,7), thus establishing the circadian system as a novel therapeutic target. Significantly, circadian and clock-controlled gene mutations have recently been identified by Genome-Wide Association Studies (GWAS) in the aetiology of sleep, mental health and metabolic disorders. This review will focus upon the genetics of circadian rhythms in sleep and health.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 20, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction to the Circadian Clock

Life has evolved under a 24-h rhythm where environmental factors such as temperature and light fluctuate with a daily predictable sequence. As a consequence, most organisms have evolved circadian clocks that anticipate these regular environmental changes and establish endogenous 24-h rhythms to get the correct physiology and behaviour to the appropriate time window each day. The mechanisms underlying circadian regulation are cell autonomous transcription-translation feedback loops (TTFLs): In mammals, the transcription factors CLOCK and BMAL1 drive the expression of Period (Per1/2) and Cryptochrome (Cry1/2), whose protein products in turn feed-back to inhibit CLOCK and BMAL1 (Fig. 1). Downstream of these four factors lie thousands of clock-controlled genes that orchestrate the oscillation of tissue-specific metabolic and physiological functions. Most cells in the body possess a molecular clock and are maintained in synchrony by a master pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus.

In order for the circadian network to have adaptive value, it must receive and respond to signals that provide temporal cues (zeitgebers). Zeitgebers modulate the temporal expression patterns of clock genes such as Per1/2, to set the phase, amplitude and period of the molecular clockwork. Light, which signals the dawn-dusk cycle, is the best-characterised zeitgeber, and this light input from the photosensitive retinal ganglion cells (pRGCs) of the retina is transmitted directly to the ventral SCN through synaptic connections, where glutamate signalling then drives cAMP response element binding factor (CREB-CRTC)-mediated transcription of Per genes in the SCN (Fig. 2). Peripheral circadian clocks throughout the body receive inputs from the SCN and numerous additional signals, including feeding; glucocorticoids; temperature; and indicators of physiological condition such as metabolic state and sleep history. The mechanisms by which many of these these zeitgebers interact with the molecular clockwork of the peripheral clocks remains unclear.

Circadian clock outputs have a profound impact upon the biology of a cell, with anywhere between 2 and 30% of each tissue’s transcriptome displaying a circadian rhythm. Interaction between clock transcription factors and tissue specific transcription factors overlay a circadian rhythm onto tissue specific gene expression patterns, resulting in the appropriate circadian transcriptome and in turn, appropriately timed physiology and behaviour. As a result, sleep and circadian rhythm disruption resulting from either social/health reasons or mutations in circadian and clock-controlled genes contributes to the development of a range of disorders. The evidence for these genetic links is discussed below with three examples: mental illness, metabolic disorders and sleep timing disruption. There is also compelling evidence for many other links between circadian disruption and conditions such as cancer and immune system disorders, which are not discussed here.

Circadian Rhythm Disruption in Mental Illness

There is considerable evidence that patients with neuropsychiatric diseases, such as bipolar disorder, schizophrenia and depression exhibit SCRD and this, alongside the evidence from mouse models has been extensively reviewed previously. This disruption encompasses a wide range of sleep perturbations, including fragmented sleep, reduced total sleep time and changes in normal sleep architecture. Furthermore, these patients show dysregulation of multiple circadian outputs and of the core molecular clock (Fig. 1). Remarkably, fibroblasts isolated from schizophrenic patients show a loss of rhythmicity in CRY1 and PER1 expression, and their peripheral blood leukocytes have decreased and/or disrupted diurnal expression of CLOCK, PER1/2/3, CRY1 and a functional CLOCK homologue NPAS2 in comparison to healthy controls. Fibroblasts isolated from bipolar patients display a larger variance in period and amplitude and deficits in the entrainment pathways. Lithium is used for the treatment of bipolar disorder, and lithium’s primary therapeutic target is postulated to be Rev-erba (Fig. 1). Additionally, patients with major depressive disorder display a marked disruption in the circadian rhythmicity and phasing of core clock genes across multiple brain regions.

It is becoming increasingly clear that disruption of the molecular clock is not just a consequence of neuropsychiatric illness, but instead forms part of a bidirectional feedback loop with neuropsychiatric disease, whereby perturbations in one exacerbate dysfunction in the other. In this context, it is worth noting that, many disease relevant processes are under circadian control, such as sleep-wake timing and monoaminergic neurotransmitter synthesis, signalling and degradation. Furthermore, multiple single nucleotide polymorphisms (SNPs) in the genes encoding the core components of the molecular clock have been demonstrated, albeit weakly, to be associated with schizophrenia, bipolar disorder and depression, suggesting a causal role for clock dysfunction in neuropsychiatric disease (Table 1).

Currently the functional consequence of these SNPs and the strength of their association with disease remains unclear, however, recent work has provided insight into how mutations may impact clock function. Two rare missense mutations in the PERIOD3 gene (PER3-P415A/H417RI), found to be associated with seasonal depression, were demonstrated to generate a mutant PER3 protein unable to stabilise PER1/2 and induce their nuclear localisation, resulting in circadian rhythm disruption.

A similar relationship has been found in patients with neurodegenerative diseases. Many conditions are associated with the disruption of sleep, circadian outputs and the core molecular clock. Patients with Alzheimer’s disease (AD) exhibit neuronal loss in the SCN, and a recent study by Lim et al. found that the diurnal and seasonal transcriptional rhythmicity of core clock genes in the dorsolateral prefrontal cortex is disrupted in AD patients. In addition, the expression of BMAL1/2 is dampened in peripheral blood leukocytes isolated from Parkinson’s disease (PD) patients.

As with neuropsychiatric illness, disruption of the core molecular clock is both a consequence of, and a contributor towards, neurodegenerative diseases. For example β-amyloid (Aβ), the neuronal aggregation of which is the hallmark of AD, causes BMAL1 degradation and therefore molecular clock disruption (Fig. 1). In animal models it has been shown that sleep deprivation leads to increased Aβ plaque formation and that sleep is required for the clearance of Aβ. Additionally, the circadian clock regulates many molecular processes commonly involved in neurodegeneration, such as oxidative stress, metabolism (see next section), neuroinflammation and protein dynamics. Evidence linking SNPs in core clock genes with neurodegenerative diseases is currently scarce, with only a limited number of studies demonstrating the association of SNPs in CLOCK, BMAL1 and/or PER1 with AD or PD. Collectively, there is currently compelling evidence that disruption of the molecular clock contributes to the progression of both neurodegenerative and neuropsychiatric conditions.

Metabolic Disorders

The metabolic system is under strong circadian control, and these relationships are summarised in Figure 3. One of the first indications of the strong coupling between circadian clocks and metabolism was suggested by the observation that the majority of cycling transcripts in the liver are implicated in multiple metabolic pathways. Processes such as glucose, cholesterol and triglyceride metabolism are a few examples, whose rate-limiting steps were shown to be major sites of circadian regulation.

Clock genes are linked directly to metabolic syndrome (MetS), both in mutant mice and humans. For example, homozygous Clock mutant mice (ClockΔ19/Δ19), which show a loss of function of this core clock gene, are obese and hyperphagic and develop a myriad of metabolic symptoms including hyperglycemia, hyperinsulinemia, hepatic steatosis and dyslipidemia, all of which are significant markers of MetS. In addition, impairing Clock function in mice suppresses gluconeogenesis and the complete knock out of Bmal1 gene abolishes it. It has also been shown that diabetes mellitus can be triggered by conditional ablation of the Clock gene in pancreatic β-cells. Clock disruption in pancreatic islets results in transcriptome-wide variations in the expression of genes involved in survival, growth and synaptic vesicle assembly within these cells. Furthermore, ClockΔ19/Δ19 mutant mice exhibit significant hypoinsulinemia and hyperglycemia as a result of abolishing their pancreatic clocks. In addition, Bmal1 levels have been shown to increase significantly during adipose differentiation in 3T3-L1 mouse embryonic cells and both knock-in and knock-down of Bmal1 support its critical involvement in adipose differentiation and lipogenesis. Cry1-/- and Cry2-/- mice show no difference in food consumption and body weight compared to wildtype animals, however, when restricted to a high-fat diet, ablation of Cry1 (yet interestingly not Cry2) prevented obesity in these mutant mice. Finally, pharmacological induction of RORa transcription factor function, an enhancer of Bmal1 expression (Fig. 1), has been shown to increase significantly the amplitude of clock rhythms and, remarkably, prevent weight gain in mice fed high-fat diets and attenuate symptoms of MetS.

In humans, like mice, polymorphisms of CLOCK and BMAL1 have been associated with metabolic disorders. For example, Clock gene polymorphisms have been linked to a higher susceptibility to obesity and two haplotypes of BMAL1 have been associated with hypertension and type 2 diabetes mellitus, replicated both in humans and in rodent models. Similar studies have also linked polymorphisms in other core clock genes like PER2 and NPAS2 to fasting hyperglycemia and hypertension respectively. In a small population of lean and obese women, a correlation between obesity and core clock components has been reported. Remarkably, being obese alters expression of core clock genes in adipocytes throughout the day and induces notable upregulation of CRY2 and REV-ERBa, two important negative feedback components of circadian clocks (Fig. 1). Furthermore, a rare SNP in visfatin (NAMPT/PBEF1), a gene known to be involved in the negative arm of the clock (not shown in Figures), has been associated with protection from obesity in human populations.

It is now evident that circadian clocks do not only regulate metabolism, but metabolic pathways can in turn feedback upon the circadian clockwork (Fig. 3). Restricting feeding to daytime (sleep phase) in mice causes uncoupling of peripheral clocks within the liver, kidney, heart and pancreas from SCN rhythms. In addition, a high-caloric diet has been shown to disrupt behavioural and molecular circadian rhythms in mice. Furthermore, two important regulators of homeostasis and metabolism in Drosophila, FOXO and GSK3b/Shaggy, were shown to be necessary for robust circadian rhythms, which emphasises the connection between metabolism and circadian clocks across the animal kingdom.

Collectively, the results from humans and animal models highlight the considerable involvement of the circadian machinery in metabolic pathways. A two-way interplay between these two systems is clear and the mechanisms governing their intercommunication are slowly emerging (Fig. 3).

Disorders of Sleep Timing

The human population displays a wide spread of circadian phenotypes or chronotypes, with early types (larks) at one end of the spectrum and late types (owls) at the other. Chronotype is influenced by an individual’s genetics, development and exposure to light and dawn and dusk. In terms of the genetics, clock gene mutations can explain some of the differences in chronotype. Two recent large scale genomic studies identified variants in several clock-related loci, particularly PER2/3, underlying morningness in the general population. Different chronotypes can usually alter sleep patterns to accommodate both their social demands and circadian clock; Winston Churchill believed in the importance of good sleep, but was a very late chronotype and compensated with long afternoon naps. However, extreme misalignment with the external light-dark cycle leads to severely disrupted sleep-wake cycles, chronic fatigue and exhaustion. The underlying cause could be either deficits in core clock machinery leading to non-24h rhythms or deficits in the input pathways and entrainment systems that result in a misaligned rhythm. Examples of the first include delayed or advanced sleep phase disorders; Familial Advanced Sleep Phase syndrome is linked to mutations in Per2 and Familial Delayed Sleep Phase Syndrome to mutations in Casein Kinase 1 Delta (Fig. 1). Recently, mutations in Cry1 have been linked to Familial Delayed Sleep Phase syndrome, with a remarkably high frequency of 0.6% in the population, thereby affecting sleep in large numbers of individuals. In these conditions, due to a faster or slower molecular clock, the time window defined by the clock as optimal to sleep is shifted with respect to the external light-dark cycle, resulting in severe misalignment. In addition, situations where input pathways are deficient are also relatively common. Low levels of light within the nursing home environment result in circadian rhythm disruption and patients with severe eye damage due to either genetic causes or trauma lose light input to the circadian clock resulting in severe misalignment. In these situations, behavioural rhythms imposed by care or feeding may help mask this disruption, but desynchronised and drifting peripheral clocks demonstrate the lack of entrainment which is manifest as poor and disrupted sleep.

Treatment of Sleep and Circadian Rhythm Disruption (SCRD)

Despite our growing knowledge of the molecular mechanisms underlying the 24h circadian clock and its role in the development of chronic and debilitating diseases, there are limited therapeutic options available for the treatment of SCRD. As light is the primary zeitgeber for the SCN clock, bright light therapies and cognitive behavioural therapies that strengthen natural zeitgebers such as scheduled outdoor exercise have been shown to have some success. However, potent pharmacological interventions are still lacking. Melatonin has long been characterised as an output of the circadian clock and can be used to modify the phase of the clock, presumably acting via the melatonin receptors that are expressed in the neurones of the SCN and multiple other cell populations across the body. Melatonin has therefore been studied as a possible chronotherapeutic drug and shows promise in certain circadian-related conditions. Prolonged release melatonin (tradename Circadin) is used to treat primary insomnia in the aged and the agonist Agomelatine in the treatment of major depressive disorder. Most recently, Tasimelteon was approved in the United States in an orphan circadian disorder, non-24h sleep-sake disorder in the totally blind. Targeting the melatonin system, however, has limited efficacy; for example, Tasimelteon showed a beneficial effect on stabilising sleep-wake in 20% of the patient population after one month of treatment. As a consequence, recent efforts have focussed on developing alternatives, mainly targeting the core clock. Solt et al. reported a novel REV-ERBa receptor agonist was effective at regulating both sleep as well as metabolism in mice and Hirota et al. have developed a small molecule Cryptochrome activator. An alternative strategy that has yet to be employed is the development of molecules that act on the light input pathway to the clock, providing a pharmacological replacement for light for the treatment of SCRD.

Acknowledgements

The authors are very grateful for valuable input and critical comments from Prof. Andrea Nemeth and Dr. Jing Yu.

Conflict of Interest statement. None declared.

References 108

  1. 1.

    Arendt J. (2010 ) Shift work: coping with the biological clock. Occup. Med. (Lond), 60, 10–20.

    Not in our library10.1093/occmed/kqp162

  2. 2.

    Wulff K., Gatti S., Wettstein J.G., Foster R.G. (2010 ) Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat. Rev. Neurosci., 11, 589–599.

    Not in our library10.1038/nrn2868

  3. 3.

    Laposky A., Easton A., Dugovic C., Walisser J., Bradfield C., Turek F. (2005 ) Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep, 28, 395–409.

    Not in our library10.1093/sleep/28.4.395

  4. 4.

    Marcheva B., Ramsey K.M., Buhr E.D., Kobayashi Y., Su H., Ko C.H., Ivanova G., Omura C., Mo S., Vitaterna M.H. (2010 ) Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature, 466, 627–631.

    Not in our library10.1038/nature09253

  5. 5.

    Jagannath A., Peirson S.N., Foster R.G. (2013 ) Sleep and circadian rhythm disruption in neuropsychiatric illness. Curr. Opin. Neurobiol., 23, 888–894.

    Not in our library10.1016/j.conb.2013.03.008

  6. 6.

    Solt L.A., Wang Y., Banerjee S., Hughes T., Kojetin D.J., Lundasen T., Shin Y., Liu J., Cameron M.D., Noel R. (2012 ) Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature, 485, 62–68.

    Not in our library10.1038/nature11030

  7. 7.

    Hatori M., Vollmers C., Zarrinpar A., DiTacchio L., Bushong E.A., Gill S., Leblanc M., Chaix A., Joens M., Fitzpatrick J.A. (2012 ) Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab., 15, 848–860.

    Not in our library10.1016/j.cmet.2012.04.019

  8. 8.

    Reppert S.M., Weaver D.R. (2002 ) Coordination of circadian timing in mammals. Nature, 418, 935–941.

    Not in our library10.1038/nature00965

  9. 9.

    Klein D.C., Moore R.Y., Reppert S.M. (1991 ) Suprachiasmatic nucleus: the mind's clock. Oxford University Press, New York.

    Not in our library

  10. 10.

    Schwartz W.J., Tavakoli-Nezhad M., Lambert C.M., Weaver D.R., de la Iglesia H.O. (2011 ) Distinct patterns of period gene expression in the suprachiasmatic nucleus underlie circadian clock photoentrainment by advances or delays. Proc. Natl Acad. Sci. U S A, 108, 17219–17224.

    Not in our library10.1073/pnas.1107848108

  11. 11.

    Hughes S., Jagannath A., Hankins M.W., Foster R.G., Peirson S.N. (2015 ) Photic regulation of clock systems. Methods Enzymol., 552, 125–143.

    Not in our library10.1016/bs.mie.2014.10.018

  12. 12.
    The CRTC1-SIK1 Pathway Regulates Entrainment of the Circadian Clock · 2013
    No notice
  13. 13.

    Stokkan K.A., Yamazaki S., Tei H., Sakaki Y., Menaker M. (2001 ) Entrainment of the circadian clock in the liver by feeding. Science, 291, 490–493.

    Not in our library10.1126/science.291.5503.490

  14. 14.

    Balsalobre A., Brown S.A., Marcacci L., Tronche F., Kellendonk C., Reichardt H.M., Schutz G., Schibler U. (2000 ) Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science, 289, 2344–2347.

    Not in our library10.1126/science.289.5488.2344

  15. 15.

    Morf J., Rey G., Schneider K., Stratmann M., Fujita J., Naef F., Schibler U. (2012 ) Cold-inducible RNA-binding protein modulates circadian gene expression posttranscriptionally. Science, 338, 379–383.

    Not in our library10.1126/science.1217726

  16. 16.

    Ramsey K.M., Yoshino J., Brace C.S., Abrassart D., Kobayashi Y., Marcheva B., Hong H.K., Chong J.L., Buhr E.D., Lee C. (2009 ) Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science, 324, 651–654.

    Not in our library10.1126/science.1171641

  17. 17.

    Yamakawa G.R., Basu P., Cortese F., MacDonnell J., Whalley D., Smith V.M., Antle M.C. (2016 ) The cholinergic forebrain arousal system acts directly on the circadian pacemaker. Proc. Natl Acad. Sci. U S A, 113, 13498–13503.

    Not in our library10.1073/pnas.1610342113

  18. 18.

    Davies S.K., Ang J.E., Revell V.L., Holmes B., Mann A., Robertson F.P., Cui N., Middleton B., Ackermann K., Kayser M. (2014 ) Effect of sleep deprivation on the human metabolome. Proc. Natl Acad. Sci. U S A, 111, 10761–10766.

    Not in our library10.1073/pnas.1402663111

  19. 19.

    Panda S., Antoch M.P., Miller B.H., Su A.I., Schook A.B., Straume M., Schultz P.G., Kay S.A., Takahashi J.S., Hogenesch J.B. (2002 ) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell, 109, 307–320.

    Not in our library10.1016/s0092-8674(02)00722-5

  20. 20.

    Duffield G.E., Best J.D., Meurers B.H., Bittner A., Loros J.J., Dunlap J.C. (2002 ) Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr. Biol., 12, 551–557.

    Not in our library10.1016/s0960-9822(02)00765-0

  21. 21.
    System-Driven and Oscillator-Dependent Circadian Transcription in Mice with a Conditionally Active Liver Clock · 2007
    No notice
  22. 22.

    Perelis M., Marcheva B., Ramsey K.M., Schipma M.J., Hutchison A.L., Taguchi A., Peek C.B., Hong H., Huang W., Omura C. (2015 ) Pancreatic beta cell enhancers regulate rhythmic transcription of genes controlling insulin secretion. Science, 350, aac4250.

    Not in our library10.1126/science.aac4250

  23. 23.
    Enhancing circadian clock function in cancer cells inhibits tumor growth · 2017
    No notice
  24. 24.

    Scheiermann C., Kunisaki Y., Frenette P.S. (2013 ) Circadian control of the immune system. Nat. Rev. Immunol., 13, 190–198.

    Not in our library10.1038/nri3386

  25. 25.

    Jagannath A., Peirson S.N., Foster R.G. Sleep and circadian rhythm disruption in neuropsychiatric illness. Curr. Opin. Neurobiol., 23, 888–894.

    Not in our library10.1016/j.conb.2013.03.008

  26. 26.

    Krystal A.D. (2012 ) Psychiatric disorders and sleep. Neurol. Clin., 30, 1389–1413.

    Not in our library10.1016/j.ncl.2012.08.018

  27. 27.

    Johansson A.S., Owe-Larsson B., Hetta J., Lundkvist G.B. (2016 ) Altered circadian clock gene expression in patients with schizophrenia. Schizophr. Res., 174, 17–23.

    Not in our library10.1016/j.schres.2016.04.029

  28. 28.

    Yin L., Wang J., Klein P.S., Lazar M.A. (2006 ) Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science, 311, 1002–1005.

    Not in our library10.1126/science.1121613

  29. 29.

    Li J.Z., Bunney B.G., Meng F., Hagenauer M.H., Walsh D.M., Vawter M.P., Evans S.J., Choudary P.V., Cartagena P., Barchas J.D. (2013 ) Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc. Natl Acad. Sci. U S A, 110, 9950–9955.

    Not in our library10.1073/pnas.1305814110

  30. 30.

    Hampp G., Albrecht U. (2008 ) The circadian clock and mood-related behavior. Commun. Integr. Biol., 1, 1–3.

    Not in our library10.4161/cib.1.1.6286

  31. 31.

    Chung S., Lee E.J., Yun S., Choe H.K., Park S.B., Son H.J., Kim K.S., Dluzen D.E., Lee I., Hwang O. (2014 ) Impact of circadian nuclear receptor REV-ERBalpha on midbrain dopamine production and mood regulation. Cell, 157, 858–868.

    Not in our library10.1016/j.cell.2014.03.039

  32. 32.

    Ikeda Y., Kumagai H., Skach A., Sato M., Yanagisawa M. (2013 ) Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior. Cell, 155, 1323–1336.

    Not in our library10.1016/j.cell.2013.10.052

  33. 33.

    Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., Monk T.H., Devlin B., Nimgaonkar V.L. (2006 ) Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav., 5, 150–157.

    Not in our library10.1111/j.1601-183x.2005.00147.x

  34. 34.

    Mansour H.A., Talkowski M.E., Wood J., Chowdari K.V., McClain L., Prasad K., Montrose D., Fagiolini A., Friedman E.S., Allen M.H. (2009 ) Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disorders, 11, 701–710.

    Not in our library10.1111/j.1399-5618.2009.00756.x

  35. 35.

    Partonen T., Treutlein J., Alpman A., Frank J., Johansson C., Depner M., Aron L., Rietschel M., Wellek S., Soronen P. (2007 ) Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann. Med., 39, 229–238.

    Not in our library10.1080/07853890701278795

  36. 36.

    Lavebratt C., Sjoholm L.K., Partonen T., Schalling M., Forsell Y. (2010 ) PER2 variantion is associated with depression vulnerability. Am. J. Med. Genet. B Neuropsychiatr. Genet., 153B, 570–581.

    Not in our library10.1002/ajmg.b.31021

  37. 37.

    Liu J.J., Hukic D.S., Forsell Y., Schalling M., Sby U., Lavebratt C. (2015 ) Depression-associated ARNTL and PER2 genetic variants in psychotic disorders. Chronobiol. Int., 32, 579–584.

    Not in our library10.3109/07420528.2015.1012588

  38. 38.

    Gonzalez R., Gonzalez S., Villa E., Ramirez M., Zavala J., Armas R., Contreras J., Dassori A., Leach R.J., Flores D. (2015 ) Identification of circadian gene variants in bipolar disorder in Latino populations. J. Affect. Disord., 186, 367–375.

    Not in our library10.1016/j.jad.2015.07.014

  39. 39.

    Chen Q., Peng X.D., Huang C.Q., Hu X.Y., Zhang X.M. (2015 ) Association between ARNTL (BMAL1) rs2278749 polymorphism T >C and susceptibility to Alzheimer disease in a Chinese population. Genet. Mol. Res., 14, 18515–18522.

    Not in our library10.4238/2015.december.23.39

  40. 40.

    Gu Z., Wang B., Zhang Y.-B., Ding H., Zhang Y., Yu J., Gu M., Chan P., Cai Y. (2015 ) Association of ARNTL and PER1 genes with Parkinson's disease: a case-control study of Han Chinese. Sci. Rep., 5, 15891.

    Not in our library10.1038/srep15891

  41. 41.

    Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., Smeraldi E. (2003 ) Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet., 123B, 23–26.

    Not in our library10.1002/ajmg.b.20038

  42. 42.

    Dmitrzak-Weglarz M.P., Pawlak J.M., Maciukiewicz M., Moczko J., Wilkosc M., Leszczynska-Rodziewicz A., Zaremba D., Hauser J. (2015 ) Clock gene variants differentiate mood disorders. Mol. Biol. Rep., 42, 277–288.

    Not in our library10.1007/s11033-014-3770-9

  43. 43.

    Takao T., Tachikawa H., Kawanishi Y., Mizukami K., Asada T. (2007 ) CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: A preliminary study. Eur. Neuropsychopharmacol., 17, 273–276.

    Not in our library10.1016/j.euroneuro.2006.09.002

  44. 44.

    Zhang J., Liao G., Liu C., Sun L., Liu Y., Wang Y., Jiang Z., Wang Z. (2011 ) The association of CLOCK gene T3111C polymorphism and hPER3 gene 54-nucleotide repeat polymorphism with Chinese Han people schizophrenics. Mol. Biol. Rep., 38, 349–354.

    Not in our library10.1007/s11033-010-0114-2

  45. 45.

    Shi S-q., White M.J., Borsetti H.M., Pendergast J.S., Hida A., Ciarleglio C.M., de Verteuil P.A., Cadar A.G., Cala C., McMahon D.G. (2016 ) Molecular analyses of circadian gene variants reveal sex-dependent links between depression and clocks. Transl. Psychiatry, 6, e748.

    Not in our library10.1038/tp.2016.9

  46. 46.

    Yang Y.-K., Peng X.-D., Li Y.-H., Wang Z.-R., Chang-quan H., Hui W., Liu Q.-X. (2013 ) The Polymorphism of CLOCK gene 3111T/C C>T is associated with susceptibility of Alzheimer disease in Chinese population. J. Investig. Med., 61, 1084–1087.

    Not in our library10.2310/jim.0b013e31829f91c0

  47. 47.

    Shi J., Wittke-Thompson J.K., Badner J.A., Hattori E., Potash J.B., Willour V.L., McMahon F.J., Gershon E.S., Liu C. (2008 ) Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet., 147B, 1047–1055.

    Not in our library10.1002/ajmg.b.30714

  48. 48.
    Circadian polymorphisms associated with affective disorders · 2009
    No notice
  49. 49.

    Soria V., Martínez-Amorós È., Escaramís G., Valero J., Pérez-Egea R., García C., Gutiérrez-Zotes A., Puigdemont D., Bayés M., Crespo J.M. (2010 ) Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology, 35, 1279–1289.

    Not in our library10.1038/npp.2009.230

  50. 50.

    Chen Q., Huang C.-Q., Hu X.-Y., Li S.-B., Zhang X.-M. (2013 ) Functional CLOCK gene rs1554483 G/C polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese population. J. Int. Med. Res., 41, 340–346.

    Not in our library10.1177/0300060513476430

  51. 51.

    Chen H-f., Huang C-q., You C., Wang Z.-R., Si-qing H. (2013 ) Polymorphism of CLOCK gene rs 4580704 C>G is associated with susceptibility of Alzheimer’s disease in a Chinese population. Arch. Med. Res., 44, 203–207.

    Not in our library10.1016/j.arcmed.2013.01.002

  52. 52.

    Drago A., Monti B., De Ronchi D., Serretti A. (2015 ) CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients. Psychiatry Investig., 12, 118.

    Not in our library10.4306/pi.2015.12.1.118

  53. 53.

    Hua P., Liu W., Chen D., Zhao Y., Chen L., Zhang N., Wang C., Guo S., Wang L., Xiao H. (2014 ) Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population. J. Affect. Disord., 157, 100–103.

    Not in our library10.1016/j.jad.2013.11.019

  54. 54.
    CRY2 Is Associated with Depression · 2010
    No notice
  55. 55.

    Kovanen L., Kaunisto M., Donner K., Saarikoski S.T., Partonen T. (2013 ) CRY2 genetic variants associate with dysthymia. PLoS One, 8, e71450.

    Not in our library10.1371/journal.pone.0071450

  56. 56.

    Kovanen L., Donner K., Kaunisto M., Partonen T. (2017 ) PRKCDBP (CAVIN3) and CRY2 associate with major depressive disorder. J. Affect. Disord., 207, 136–140.

    Not in our library10.1016/j.jad.2016.09.034

  57. 57.

    Lavebratt C., Sjöholm L.K., Partonen T., Schalling M., Forsell Y. (2009 ) PER2 variantion is associated with depression vulnerability. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet., 9999B, n/a-n/a.

    Not in our library10.1002/ajmg.b.31021

  58. 58.

    Maglione J.E., Nievergelt C.M., Parimi N., Evans D.S., Ancoli-Israel S., Stone K.L., Yaffe K., Redline S., Tranah G.J. and Groups, S.o.O.F.i.W.S.a.O.F.i.M.S.M.R. (2015 ) Associations of PER3 and RORA circadian gene polymorphisms and depressive symptoms in older adults. Am. J. Geriatr. Psychiatry, 23, 1075–1087.

    Not in our library10.1016/j.jagp.2015.03.002

  59. 59.

    Terracciano A., Tanaka T., Sutin A.R., Sanna S., Deiana B., Lai S., Uda M., Schlessinger D., Abecasis G.R., Ferrucci L. (2010 ) Genome-wide association scan of trait depression. Biol. Psychiatry, 68, 811–817.

    Not in our library10.1016/j.biopsych.2010.06.030

  60. 60.

    Etain B., Jamain S., Milhiet V., Lajnef M., Boudebesse C., Dumaine A., Mathieu F., Gombert A., Ledudal K., Gard S. (2014 ) Association between circadian genes, bipolar disorders and chronotypes. Chronobiol. Int., 31, 807–814.

    Not in our library10.3109/07420528.2014.906445

  61. 61.

    Lai Y.-C., Kao C.-F., Lu M.-L., Chen H.-C., Chen P.-Y., Chen C.-H., Shen W.W., Wu J.-Y., Lu R.-B., Kuo P.-H. (2015 ) Investigation of associations between NR1D1, RORA and RORB genes and bipolar disorder. plos One, 10, e0121245.

    Not in our library10.1371/journal.pone.0121245

  62. 62.

    Bedrosian T.A., Fonken L.K., Nelson R.J. (2016 ) Endocrine effects of circadian disruption. Annu. Rev. Physiol., 78, 109–131.

    Not in our library10.1146/annurev-physiol-021115-105102

  63. 63.

    Zhang L., Hirano A., Hsu P.K., Jones C.R., Sakai N., Okuro M., McMahon T., Yamazaki M., Xu Y., Saigoh N. (2016 ) A PERIOD3 variant causes a circadian phenotype and is associated with a seasonal mood trait. Proc. Natl Acad. Sci. U S A, 113, E1536–E1544.

    Not in our library10.1073/pnas.1600039113

  64. 64.

    Musiek E.S. (2015 ) Circadian clock disruption in neurodegenerative diseases: cause and effect?. Front. Pharmacol., 6, 29.

    Not in our library10.3389/fphar.2015.00029

  65. 65.

    Wang J.L., Lim A.S., Chiang W.Y., Hsieh W.H., Lo M.T., Schneider J.A., Buchman A.S., Bennett D.A., Hu K., Saper C.B. (2015 ) Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann. Neurol., 78, 317–322.

    Not in our library10.1002/ana.24432

  66. 66.

    Lim A.S., Klein H.U., Yu L., Chibnik L.B., Ali S., Xu J., Bennett D.A., De Jager P.L. (2017 ) Diurnal and seasonal molecular rhythms in human neocortex and their relation to Alzheimer's disease. Nat. Commun., 8, 14931.

    Not in our library10.1038/ncomms14931

  67. 67.

    Cai Y., Liu S., Sothern R.B., Xu S., Chan P. (2010 ) Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur. J. Neurol., 17, 550–554.

    Not in our library10.1111/j.1468-1331.2009.02848.x

  68. 68.

    Ding H., Liu S., Yuan Y., Lin Q., Chan P., Cai Y. (2011 ) Decreased expression of Bmal2 in patients with Parkinson's disease. Neurosci. Lett., 499, 186–188.

    Not in our library10.1016/j.neulet.2011.05.058

  69. 69.
    Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer’s disease · 2015
    No notice
  70. 70.

    Kang J.E., Lim M.M., Bateman R.J., Lee J.J., Smyth L.P., Cirrito J.R., Fujiki N., Nishino S., Holtzman D.M. (2009 ) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science, 326, 1005–1007.

    Not in our library10.1126/science.1180962

  71. 71.

    Musiek E.S., Lim M.M., Yang G., Bauer A.Q., Qi L., Lee Y., Roh J.H., Ortiz-Gonzalez X., Dearborn J.T., Culver J.P. (2013 ) Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J. Clin. Invest., 123, 5389–5400.

    Not in our library10.1172/jci70317

  72. 72.

    Hayashi Y., Koyanagi S., Kusunose N., Okada R., Wu Z., Tozaki-Saitoh H., Ukai K., Kohsaka S., Inoue K., Ohdo S. (2013 ) The intrinsic microglial molecular clock controls synaptic strength via the circadian expression of cathepsin S. Sci. Rep., 3, 2744.

    Not in our library10.1038/srep02744

  73. 73.

    Fonken L.K., Frank M.G., Kitt M.M., Barrientos R.M., Watkins L.R., Maier S.F. (2015 ) Microglia inflammatory responses are controlled by an intrinsic circadian clock. Brain Behav. Immun., 45, 171–179.

    Not in our library10.1016/j.bbi.2014.11.009

  74. 74.

    Musiek E.S., Holtzman D.M. (2016 ) Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science, 354, 1004–1008.

    Not in our library10.1126/science.aah4968

  75. 75.

    Kornmann B., Schaad O., Reinke H., Saini C., Schibler U. (2007 ) Regulation of circadian gene expression in liver by systemic signals and hepatocyte oscillators. Cold Spring Harb. Symp. Quant. Biol., 72, 319–330.

    Not in our library10.1101/sqb.2007.72.041

  76. 76.

    Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R. (2005 ) Obesity and metabolic syndrome in circadian Clock mutant mice. Science, 308, 1043–1045.

    Not in our library10.1126/science.1108750

  77. 77.
    BMAL1 and CLOCK, Two Essential Components of the Circadian Clock, Are Involved in Glucose Homeostasis · 2004
    No notice
  78. 78.

    Shimba S., Ishii N., Ohta Y., Ohno T., Watabe Y., Hayashi M., Wada T., Aoyagi T., Tezuka M. (2005 ) Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. Proc. Natl Acad. Sci. U S A, 102, 12071–12076.

    Not in our library10.1073/pnas.0502383102

  79. 79.

    Griebel G., Ravinet-Trillou C., Beeske S., Avenet P., Pichat P. (2014 ) Mice deficient in cryptochrome 1 (cry1 (-/-)) exhibit resistance to obesity induced by a high-fat diet. Front. Endocrinol. (Lausanne), 5, 49.

    Not in our library10.3389/fendo.2014.00049

  80. 80.

    He B., Nohara K., Park N., Park Y.S., Guillory B., Zhao Z., Garcia J.M., Koike N., Lee C.C., Takahashi J.S. (2016 ) The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab., 23, 610–621.

    Not in our library10.1016/j.cmet.2016.03.007

  81. 81.

    Scott E.M., Carter A.M., Grant P.J. (2008 ) Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int. J. Obes. (Lond), 32, 658–662.

    Not in our library10.1038/sj.ijo.0803778

  82. 82.

    Sookoian S., Gemma C., Gianotti T.F., Burgueno A., Castano G., Pirola C.J. (2008 ) Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am. J. Clin. Nutr., 87, 1606–1615.

    Not in our library10.1093/ajcn/87.6.1606

  83. 83.

    Woon P.Y., Kaisaki P.J., Braganca J., Bihoreau M.T., Levy J.C., Farrall M., Gauguier D. (2007 ) Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc. Natl Acad. Sci. U S A, 104, 14412–14417.

    Not in our library10.1073/pnas.0703247104

  84. 84.
    NPAS2 and PER2 are linked to risk factors of the metabolic syndrome · 2009
    Not checked
  85. 85.
    Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome. · 2014
    Not checked
  86. 86.

    Nakahata Y., Sahar S., Astarita G., Kaluzova M., Sassone-Corsi P. (2009 ) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science, 324, 654–657.

    Not in our library10.1126/science.1170803

  87. 87.

    Blakemore A.I., Meyre D., Delplanque J., Vatin V., Lecoeur C., Marre M., Tichet J., Balkau B., Froguel P., Walley A.J. (2009 ) A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity. Obesity (Silver Spring), 17, 1549–1553.

    Not in our library10.1038/oby.2009.75

  88. 88.

    Damiola F., Le Minh N., Preitner N., Kornmann B., Fleury-Olela F., Schibler U. (2000 ) Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev., 14, 2950–2961.

    Not in our library10.1101/gad.183500

  89. 89.

    Kohsaka A., Laposky A.D., Ramsey K.M., Estrada C., Joshu C., Kobayashi Y., Turek F.W., Bass J. (2007 ) High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab., 6, 414–421.

    Not in our library10.1016/j.cmet.2007.09.006

  90. 90.

    Martinek S., Inonog S., Manoukian A.S., Young M.W. (2001 ) A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock. Cell, 105, 769–779.

    Not in our library10.1016/s0092-8674(01)00383-x

  91. 91.

    Zheng X., Yang Z., Yue Z., Alvarez J.D., Sehgal A. (2007 ) FOXO and insulin signaling regulate sensitivity of the circadian clock to oxidative stress. Proc. Natl Acad. Sci. U S A, 104, 15899–15904.

    Not in our library10.1073/pnas.0701599104

  92. 92.
    GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person · 2016
    No notice
  93. 93.
    Genome-Wide Association Analyses in 128,266 Individuals Identifies New Morningness and Sleep Duration Loci · 2016
    No notice
  94. 94.

    Jenkins R. (2001 ) Churchill: A Biography. Farrar, Straus and Giroux, New York.

    Not in our library

  95. 95.

    Toh K.L., Jones C.R., He Y., Eide E.J., Hinz W.A., Virshup D.M., Ptacek L.J., Fu Y.H. (2001 ) An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science, 291, 1040–1043.

    Not in our library10.1126/science.1057499

  96. 96.

    Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N., Saigoh K., Ptacek L.J., Fu Y.H. (2005 ) Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature, 434, 640–644.

    Not in our library10.1038/nature03453

  97. 97.

    Patke A., Murphy P.J., Onat O.E., Krieger A.C., Ozcelik T., Campbell S.S., Young M.W. (2017 ) Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder. Cell, 169, 203–215. e213.

    Not in our library10.1016/j.cell.2017.03.027

  98. 98.

    Most E.I., Scheltens P., Van Someren E.J. (2010 ) Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light–a randomized clinical trial. Trials, 11, 19.

    Not in our library10.1186/1745-6215-11-19

  99. 99.

    Sack R.L., Lewy A.J., Blood M.L., Keith L.D., Nakagawa H. (1992 ) Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J. Clin. Endocrinol. Metab., 75, 127–134.

    Not in our library10.1210/jcem.75.1.1619000

  100. 100.

    Atkinson G., Edwards B., Reilly T., Waterhouse J. (2007 ) Exercise as a synchroniser of human circadian rhythms: an update and discussion of the methodological problems. Eur. J. Appl. Physiol., 99, 331–341.

    Not in our library10.1007/s00421-006-0361-z

  101. 101.

    Zee P.C., Attarian H., Videnovic A. (2013 ) Circadian rhythm abnormalities. Continuum (Minneap Minn), 19, 132–147.

    Not in our library10.1212/01.con.0000427209.21177.aa

  102. 102.

    Dahlitz M., Alvarez B., Vignau J., English J., Arendt J., Parkes J.D. (1991 ) Delayed sleep phase syndrome response to melatonin. Lancet, 337, 1121–1124.

    Not in our library10.1016/0140-6736(91)92787-3

  103. 103.

    Mundey K., Benloucif S., Harsanyi K., Dubocovich M.L., Zee P.C. (2005 ) Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep, 28, 1271–1278.

    Not in our library10.1093/sleep/28.10.1271

  104. 104.

    Lemoine P., Wade A.G., Katz A., Nir T., Zisapel N. (2012 ) Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials. Integr. Blood Press Control, 5, 9–17.

    Not in our library10.2147/ibpc.s27240

  105. 105.

    Kennedy S.H., Emsley R. (2006 ) Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur. Neuropsychopharmacol., 16, 93–100.

    Not in our library10.1016/j.euroneuro.2005.09.002

  106. 106.

    Lockley S.W., Dressman M.A., Licamele L., Xiao C., Fisher D.M., Flynn-Evans E.E., Hull J.T., Torres R., Lavedan C., Polymeropoulos M.H. (2015 ) Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet, 386, 1754–1764.

    Not in our library10.1016/s0140-6736(15)60031-9

  107. 107.

    Banerjee S., Wang Y., Solt L.A., Griffett K., Kazantzis M., Amador A., El-Gendy B.M., Huitron-Resendiz S., Roberts A.J., Shin Y. (2014 ) Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour. Nat. Commun., 5, 5759.

    Not in our library10.1038/ncomms6759

  108. 108.

    Hirota T., Lee J.W., St John P.C., Sawa M., Iwaisako K., Noguchi T., Pongsawakul P.Y., Sonntag T., Welsh D.K., Brenner D.A. (2012 ) Identification of small molecule activators of cryptochrome. Science, 337, 1094–1097.

    Not in our library10.1126/science.1223710

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.